CanFinis Therapeutics is an Indian company based in Kolkata focused on developing CAR-T therapy for the treatment of solid tumours. CanFinis was started by Harvard trained scientists, entrepreneurs and clinicians with an aim to develop unique personalized cell therapies for the cancer treatment. The company is incubated at one of the state of the art R&D centre in Kolkata and has another research facility in north India. Using one of the proprietary Tumor micro environment platform, the company is validating CAR-T in vitro in physiological conditions of tumour micro environment and has aim to complete the pre-clinical development by the end of 2024
Company Details
- Employees
- 4
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Ahmedabad.
Canfinis Therapeutics Questions
Canfinis Therapeutics's LinkedIn profile is https://www.linkedin.com/company/canfinistherapeutics
Canfinis Therapeutics has
4 employees.
View email and phone details for 4
employees at Canfinis Therapeutics.
Canfinis Therapeutics's industry is
Biotechnology Research
Canfinis Therapeutics's top competitors are
Rxdispolabs,
Enjoy Finserve Pvt Ltd,
Trisalus Life Sciences,
Canbro Healthcare,
Msn Laboratories,
Gmaaf,
Cellworks,
Hallmark Formulations Pharmaceuticals - India,
Nightingale Hospital (Kolkata),
Abc-Pharm Llc.
Canfinis Therapeutics's categories are Biotechnology Research
